Stay updated with breaking news from Poster Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At American Association for Cancer Research Annual Meeting 2022 New Orleans, April 8 13 Regulatory News: OSE Immunotherapeutics (Paris:OSE)(ISIN: FR0012127173; Mnemo: OSE), today announced that
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced phase 1b data demonstrating clinical proof-of-concept for...
Investegate announcements from Ultimovacs ASA, Ultimovacs to Present Preclinical Data on TET Platform at American Association for Cancer Research (AACR) 2022 Annual Meeting
Oslo, March 9, 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced that it will present data on the preclinical evaluation of the